v2.4.0.6
Income Taxes Income Taxes (Tables)
12 Months Ended
Dec. 31, 2011
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The jurisdictional components of income (loss) from continuing operations before income tax expense (benefit), attributable to Calpine, for the years ended December 31, 2011, 2010 and 2009, are as follows (in millions):
 
2011
 
2010
 
2009
U.S.
$
(232
)
 
$
(226
)
 
$
116

International
20

 
(4
)
 
13

Total
$
(212
)
 
$
(230
)
 
$
129

Schedule of Components of Income Tax Expense (Benefit)
The components of income tax expense (benefit) from continuing operations for the years ended December 31, 2011, 2010 and 2009, consisted of the following (in millions):
 
2011
 
2010
 
2009
Current:
 
 
 
 
 
Federal
$
(16
)
 
$
(1
)
 
$
(2
)
State
12

 
10

 
(2
)
Foreign
3

 
3

 
3

Total current
(1
)
 
12

 
(1
)
Deferred:
 
 
 
 
 
Federal
(33
)
 
(70
)
 
13

State
9

 

 
4

Foreign
3

 
(10
)
 
(1
)
Total deferred
(21
)
 
(80
)
 
16

Total income tax expense (benefit)
$
(22
)
 
$
(68
)
(1) 
$
15

_________
(1)
Includes approximately $13 million in intraperiod tax expense related to a prior period with an offsetting benefit in OCI.
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the federal statutory rate of 35% to our effective rate from continuing operations for the years ended December 31, 2011, 2010 and 2009, is as follows:
 
2011
 
2010
 
2009
Federal statutory tax expense (benefit) rate
(35.0
)%
 
(35.0
)%
 
35.0
 %
State tax expense (benefit), net of federal benefit
6.5

 
2.8

 
1.0

Depletion in excess of basis

 
(1.3
)
 

Valuation allowances against future tax benefits
56.7

 
33.6

 
(139.2
)
Valuation allowances related to reconsolidation of CCFC
(36.0
)
 

 

Foreign taxes
(0.9
)
 
9.9

 
(9.2
)
Non-deductible reorganization items
0.5

 
0.3

 
1.3

Income from cancellation of indebtedness

 

 
69.0

Intraperiod allocation
19.9

 
(40.1
)
 
45.4

Bankruptcy settlement
(15.7
)
 

 

Change in unrecognized tax benefits
(6.6
)
 
0.6

 
1.4

Permanent differences and other items
0.2

 
(0.4
)
 
6.9

Effective income tax expense (benefit) rate
(10.4
)%
 
(29.6
)%
 
11.6
 %
Schedule of Deferred Tax Assets and Liabilities
The components of the deferred income taxes as of December 31, 2011 and 2010, are as follows (in millions):
 
2011
 
2010
Deferred tax assets:
 
 
 
NOL and credit carryforwards
$
3,290

 
$
3,138

Taxes related to risk management activities and derivatives
58

 
18

Reorganization items and impairments
318

 
422

Foreign capital losses
24

 
25

Other differences
26

 
12

Deferred tax assets before valuation allowance
3,716

 
3,615

Valuation allowance
(2,336
)
 
(2,386
)
Total deferred tax assets
1,380

 
1,229

Deferred tax liabilities: property, plant and equipment
(1,364
)
 
(1,280
)
Net deferred tax asset (liability)
16

 
(51
)
Less: Current portion deferred tax asset (liability)
(2
)
 
(4
)
Less: Non-current deferred tax asset
18

 
30

Deferred income tax liability, non-current
$

 
$
(77
)
Schedule of Income Tax Expense (Benefit) Intraperiod Tax Allocation
The following table details the effects of our intraperiod tax allocations for the year ended December 31, 2011, 2010 and 2009 (in millions).
 
2011
 
2010
 
2009
Intraperiod tax allocation expense (benefit) included in continuing operations
$
42

 
$
(86
)
 
$
43

Intraperiod tax allocation expense (benefit) included in discountinued operations
$

 
$
59

 
$

Intraperiod tax allocation expense (benefit) included in OCI
$
(45
)
 
$
27

 
$
(43
)
Schedule of Income Tax Contingencies
A reconciliation of the beginning and ending amounts of our unrecognized tax benefits for the years ended December 31, 2011, 2010 and 2009, is as follows (in millions):
 
2011
 
2010
 
2009
Balance, beginning of period
$
(88
)
 
$
(98
)
 
$
(90
)
Increases related to prior year tax positions

 
(1
)
 
(11
)
Decreases related to prior year tax positions
1

 
11

 
2

Settlements

 

 
1

Decrease related to lapse of statute of limitations
13

 

 

Balance, end of period
$
(74
)
 
$
(88
)
 
$
(98
)